Thailand's cannabis market did not collapse. It consolidated.

Every headline about Thailand's cannabis market since 2024 uses the same word: collapse. It is the wrong word. What happened was consolidation, and if you are sizing an entry or a competitor on the assumption that this market shrank in proportion to its shop closures, you are working from the wrong picture.

Start with the number that anchors the collapse narrative. The legal market peaked in 2024 at roughly $1.44 billion and then drew down 36.5% Certain from that high. That figure is real, it is public, and it is the one every incumbent forecast now has to explain away. But a drawdown in dollar terms and a collapse in market structure are two different events, and Thailand went through the first without fully going through the second.

Read the shop-closure data correctly

The more visible number is the storefront count, and it looks brutal on its face: of roughly 18,433 shops operating at peak, about 7,297 closed by early 2026, leaving about 11,136 still operating Certain. Divide those two figures and you get a shop-count decline near 40%, which lines up neatly with the revenue drawdown and invites a simple conclusion: the market lost forty percent of itself and that is the whole story.

It is not the whole story, because closures and revenue loss were not evenly distributed across the operator base. The shops that closed were disproportionately the weakest cohort from the 2022 to 2023 gold-rush entry: undercapitalized, thin on compliance infrastructure, opened to catch a wave rather than to run a business built for a controlled-herb regime. Their exit removed shop count far faster than it removed revenue, because their revenue per location was already small. The stronger operators did not just survive the shakeout. They absorbed the customers, the locations, and the transaction volume the weak operators left behind.

The topline held closer to its former self than the headlines suggest

This is the part that gets lost when the story is told purely through shop-closure counts. The national market did draw down 36.5% from its 2024 peak, but the revenue that remained did not fragment across the surviving 11,136 shops evenly. It concentrated. Fewer operators are now doing measurably more volume each, absorbing share from the ones that folded, and running tighter operations than the peak-era median. The result is a market whose current size sits meaningfully closer to its old high than a naive read of the closure rate would predict.

We size the current national retail market at Likely, reconstructed from the ground rather than modeled from a press release. the exact figure is in the report → The point is not the specific number. The point is the shape: closer to the 2024 peak than to a market that lost forty percent of its shops and therefore, by the lazy assumption, forty percent of its revenue.

Where the concentration shows up

The clearest evidence of consolidation sits in how value now moves through the supply chain, from farm-gate to wholesale to the retail shelf. That three-layer split has shifted meaningfully since 2024, and the shift is itself a signal of which segment of the market absorbed the surviving demand. We hold the current channel value split confidence-tagged in the full report rather than in this post Likely, because it is one of the clearest fingerprints of consolidation and one of the figures competitors would most like to have for free. see the channel split in the report →

What we can say plainly is the direction: capital and customer flow moved toward operators who could absorb the compliance burden of the post-June-2025 controlled-herb framework, who could sustain PT 33 prescription workflows at scale, and who had the balance sheet to outlast a price war. That is not a market in freefall. That is a market sorting itself by operator quality, which is precisely what consolidation looks like from the inside while it reads as collapse from the outside.

Why this matters for entry timing

If you model Thailand as a market still falling, you wait for a bottom you have already missed, or you discount an entry price against a downside that is not the live risk. The live risk here is not another leg down. It is oversupply and price compression inside a stabilizing base, which is a different problem with a different solution: partner with, acquire, or out-execute the operators who already absorbed the shakeout, rather than betting on a rebound from a floor that has already formed.

If you model it as collapsed and irrelevant, you miss that a smaller number of operators are now running a business closer in scale to the peak-era market than the shop-closure headlines imply, with cleaner compliance postures and a clearer read on the controlled-herb regime than anyone operating in the gold-rush years ever had.

How we know this: this reconstruction is built from the ground, not from a spreadsheet extrapolation. Our field program covered 850+ dispensaries visited across the country, including 650 in Bangkok, more than 100 owner and operator interviews across ten-plus nationalities, and 30+ farm operators, alongside the licensing process completed first-hand rather than described secondhand.